Replies to post #146155 on SMART MONEY GROUP

[stock1ace1]

Mvis $3.00 p/m buyout watch

[stock1ace1]

EXTR $5.00 gapping on earnings p/m

[Buyfor1sell for2]

No its still going still at 11400 range, I have a few, lol

[~ Blue ~]

$VAL hit .77 pre-market yesterday called at .39 https://investorshub.advfn.com/boards/read_msg.aspx?message_id=157354852

[Buyfor1sell for2]

MYOS - MYOS RENS Technology's Net Revenues Increase 114% and Operating Expenses Decrease 26% for the Three Months Ended June 30, 2020
[8:01 AM]

[twotickets]

QUTR now CURRENT!! https://www.otcmarkets.com/stock/QUTR/overview

[jackson73]

TORC merger agreement...Adicet Receives $10 Million payment...

https://finance.yahoo.com/news/adicet-bio-receives-10-million-110000835.html

https://www.finviz.com/quote.ashx?t=torc&ty=c&ta=1&p=d

Big gap in that chart after 3.00 break

on watch

About the Proposed Merger with resTORbio
On April 29, 2020, Adicet and resTORbio, Inc. (Nasdaq: TORC) announced that they entered into a definitive merger agreement to create a combined publicly-traded biotechnology company focused on the development of Adicet's off-the-shelf allogeneic gamma delta T cell therapies for oncology and other indications. The merger is expected to close in the second half of 2020, subject to approvals of each company's stockholders and other customary closing conditions. Upon completion of the merger, the combined company will operate under the name Adicet Bio and is expected to trade on the Nasdaq Global Market under the ticker symbol ACET.